igf-1 lr3 starting dose (1 mg Vial) Unlocking the Power of IGF-1

Sousa-Victor et al., 2014)

In a rat model of cerebral ischemia-induced neurological impairment, the co-administration of tissue plasminogen activator (tPA) with nanoliposomal Fasudil-Lip showed better neuroprotection, and prolonged therapeutic time window (TTW) and improved drug targeting (Fukuta et al., 2017)

Drugs 12, 5035 (2014), Application(s): Microplate Reader

Purity is strong, too, with a minimum of 99% and an average of 99.7% across the catalog, verified by independent HPLC and mass spec

[11,13] Dowody naukowe (skuteczno): Chocia badania na zwierztach i niektre starsze rosyjskie badania sugeruj wyduenie ycia u zwierzt, wspczesna nauka zachodnia nie dysponuje wystarczajcymi danymi klinicznymi wysokiej jakoci, aby potwierdzi te efekty u ludzi